Treatment outcomes with acute pharmacotherapy/psychotherapy

Depression: Treatment Strategies and Management

Volumn , Issue , 2006, Pages 85-122

  Schwartz, Thomas L ^a   Stormon, Lynn ^a   Thase, Michael E ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845973470     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (234)

1. Thase ME, Kupfer DJ. Recent developments in the pharmacotherapy of mood disorders. J Consult Clin Psychol 1996; 64:646-659.
2. Stahl SM. J Clin Psychiat 2003; 64(11):1282-1283.
3. Morris JB, Beck AT. The efficacy of antidepressant drugs: a review of research (1958-1972). Arch Gen Psychiat 1974; 30:667-674.
4. Klein DF, Gittelman R, Quitkin F, Rifkin A. Diagnosis and Drug Treatment of Psychiatric Disorders: Adult and Children. 2d ed. Baltimore, MD: Williams & Wilkins, 1980.
5. Depression Guideline Panel. Depression in Primary Care. Treatment of Major Depression. Vol. 2. Rockville, MD: US Depart of Health and Human Services Agency for Health Care Policy and Research, 1993. Clinical Practice Guideline Number 5. AHCPR publication 93-0551.
6. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiat 2000; 157(suppl 4):1-45.
7. Thase ME. Studying new antidepressants: if there was a light at the end of the tunnel could we see it? J Clin Psychiat 2002; 63(suppl 2):24-28.
8. Thase ME. Comparing the methods used to compare antidepressants. Psychopharmacol Bull 2002; 36(suppl 1):4-17.
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23:56-62.
10. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiat 1979; 134:382-389.
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.
12. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention Treatment 2002; 5 (Article 23) (http://journals.apa.org/prevention/volume5/pre0050023a.html).
13. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies ofmajor depression: variable, substantial, and growing. JAMA 2002; 287:1840-1847.
14. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiat 2000; 57:311-317.
15. Stahl SM, Entsuah R, Rudolph RL. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Biol Psychiat 2002; 52:1166-1174.
16. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiat 1991; 48:851-855.
17. Thase ME, Sloan DM, Kornstein S. Remission as the critical outcome of depression treatment. Psychopharmacol Bull 2002; 36(suppl 3):12-25.
18. Zimmerman M, Posternak MA, Chelminski I. Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 2004; 19:215-220.
19. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995; 25:1171-1180.
20. Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive BT of depression: potential implications for longer courses of treatment? Am J Psychiat 1992; 149:1046-1052.
21. Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression. Part 3: Psychosocial functioning before and after treatment with sertraline and imipramine. J Clin Psychiat 1998; 59:608-619.
22. Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 1995; 12:185-219.
23. Stewart JS, McGrath PJ, Rabkin JG, Quitkin FM. A typical depression: a valid clinical entity? Psychiat Clin North Am 1993; 16(3):479-495.
24. Buckley NA, McManus PR. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of UK mortality data. BMJ 2002; 325:1332-1333.
25. Buckley NA, Faunce TA. 'Atypical' antidepressants in overdose: clinical considerations with respect to safety. Drug Saf 2003; 26:539-551.
26. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306:683-687.
27. Anderson IM, Tomenson BM. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8:238-249.
28. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58:19-36.
29. Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Br J Psychiat 2000; 177:292-302.
30. Barbui C, Hotopf M. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br J Psychiat 2001; 178:129-144.
31. Montgomery SA, Henry J, McDonald G, et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9:47-53.
32. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998; 279:287-291.
33. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiat 2000; 157(9):1445-1452.
34. Anderson IM. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 1998; 7(suppl 1): 11-17.
35. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999; 57:507-533. [Erratum appears in Drugs 1999; 58(6):1207-1209].
36. Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001; 57:161-178.
37. Gorman JM, Korotzer A, Su G. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials. CNS Spectrums 2002; 7(suppl 1):40-44.
38. Svensson S, Mansfield PR. Escitalopram: superior to citalopram or chiral chimera? Psychother Psychosomat 2004; 73:10-16.
39. Storustovu SI, Sanchez C, Porzgen P, et al. R-citalopram functionally antagonizes escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter. Br J Pharmacol 2004; 142:172-180.
40. Baron BM, Ogden A, Siegel BW, Stegeman J, Ursillo RC, Dudley MW. Rapid down regulation of B adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 1988; 154:125-134.
41. Clerc GE, Ruimy P, Verdeau PJ. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalised for major depression and melancholia. Int Clin Psychopharmacol 1994; 9:139-143.
42. Dierick M, Ravizza L, Realini R, Martin A. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuropsychopharmacol Biol Psychiat 1996; 20:57-71.
43. Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52: 1023-1029.
44. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiat 1998; 59(10):502-508.
45. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual action of venlafaxine. Arch Gen Psychiat 2000; 57:503-509.
46. Olver JS, Burrrows GD, Norman TR. The treatment of depression with different formulations of venlafaxine: a comparative analysis. Hum Psychopharmacol 2004; 19:9-16.
47. Thase ME, Friedman ES, Howland RH. Venlafaxine and treatment-resistant depression. Depress Anxiety 2000; 12(suppl 1):55-62.
48. Kelsey JE. Dose-response relationship with venlafaxine. J Clin Psychopharmacol 1996; 16:21S-26S.
49. Khan A, Upton GV, Rudolph RL, Entsuah R, Leventer SM. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. J Clin Psychopharmacol 1998; 18:19-25.
50. Einarson TR, Arikian SR, Casciano J, Doyle JJ. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic anti-depressants in the treatment of depression: a meta-analysis of randomized controlled trials. Clin Ther 1999; 21:296-308.
51. Smith D, Dempster C, Glanville J, Freemantle N, Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiat 2002; 180:396-404.
52. Thase ME, Entsuah AR, Rudolph RI. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiat 2001; 178:234-241.
53. Nemeroff CB, Entsuah AR, Willard L, Demitrack M, Thase M. Venlafaxine and SSRIs: pooled remission analysis. Eur Neuropsychopharmacol 2003; 13(suppl 4):S255.
54. Nemeroff C. Poster Presented at 2003 American Psychiatric Association Annual Meeting, San Francisco.
55. Thase ME, Entsuah P, Cantillon M, Kornstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Women's Health 2005; 14(7):609-616.
56. Shelton C, Entsuah P, Padmanabhan SK, Vinall PE. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxemine or placebo. Int Clin Psychopharm 2005; 20(4):233-238.
57. Shelton RC, Haman K, Kiev A, et al. NR380 sertraline versus venlafaxine extended release in depressed outpatients. Poster presented at American Psychiatric Association Annual Meeting 2004, New York.
58. Bielski RJ, Ventura D, Chang CC. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. J Clin Psychiat 2004.
59. Poirier M-F, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomised comparison. Br J Psychiat 1999; 175:12-16.
60. Spencer CM, Wilde MI. Milnacipran. A review of its use in depression. Drugs 1998; 56:405-427.
61. Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiat 2004; 55:320-322.
62. Puech A, Montgomery S, Prost JF, Solles A, Briley M. Milnacipran, a new serotonin and noradrenaline reuptake: an overview of its antidepressant effects and clinical tolerability. Int Clin Psychopharmacol 1997; 12:99-108.
63. Fukuchi T, Kanemotto K. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. Int Clin Psychopharmacol 2002; 17:53-58.
64. Guelfi JD, Ansseau M, Corruble E, et al. A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed patients. Int Clin Psychopharmacol 1998; 13:121-128.
65. Clerc G. Milnacipran/fluvoxamine study group. Antidepressant efficacy and tolerability of milnacipran a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. Int Clin Psychopharmacol 2001; 16:145-151.
66. Morishita S, Aritz S. Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression. Hum Psychopharmacol 2003; 18:479-482.
67. Ansseau M, von Frenckell R, Gerard M-A, et al. Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine. Eur Neuropsychopharmacol 1991; 1:113-121.
68. Ansseau M, Papart P, Troisfontaines B, et al. Controlled comparison of milnacipran and fluoxetine in major depression. Psychopharmacology 1994; 114:131-137.
69. Nemeroff CB, Schatzberg AF, Goldstein DJ, et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull 2002; 36:106-132.
70. Thase ME, Tran PV, Wiltse C, Pangallo BA, Mallinckrodt C, Detke MJ. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol 2005; 25:132-140.
71. Thase M, Schutte AJ, Van der flier S, Heukels A. Remission with mirtazapine versus SSRIs: a meta analysis on data of more than 2500 depressed patients treated in randomized controlled trials. J Affect Disord 2004; 78(suppl 1):S136.
72. Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol 2002; 22:40-45.
73. Rush AJ, Armitage R, Gillin JC, et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiat 1998; 44:3-14.
74. Feiger AD, Bielski RJ, Bremner J, et al. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. Int Clin Psychopharmacol 1999; 14:19-28.
75. Ferguson JM, Shrivastava RK, Stahl SM, et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double blind comparison of nefazodone and sertraline. J Clin Psychiat 2001; 62:24-29.
76. Quitkin FM, Taylor BP, Kremer C. Does mirtazapine have a more rapid onset than SSRIs? J Clin Psychiat 2001; 62:358-361.
77. Thase ME, Howland RH, Friedman ES. Onset of action of selective and multi-action antidepressants. In: den Boer JA, Westenberg HGM, eds. Antidepressants: Selectivity or Multiplicity? Benecke, NI: Amsterdam, The Netherlands, 2001:101-116.
78. Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S. Mirtazapine-venlafaxine study group. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. J Clin Psychopharmacol 2001; 21:425-431.
79. Ferster CB. A functional analysis of depression. Am Psychol 1973; 28: 857-870.
80. Liberman RP, Raskin DE. Depression. A behavioral formulation. Arch Gen Psychiat 1971; 24:515-523.
81. Rush AT. Psychotherapy of the affective psychoses. Am J Psychoanal 1980; 40:99-123.
82. Weissman MM. The psychological treatment of depression: research evidence for the efficacy of psychotherapy alone, in comparison and in combination with pharmacotherapy. Arch Gen Psychiat 1979; 36:1261-1269.
83. Arieti S. Affective disorders: manic-depressive psychosis and psychotic depression: manifest symptomatology, psychodynamics, sociological factors and psychotherapy. In: Arieti S, ed. American Handbook of Psychiatry. Basic Books. New York: Basic Books, 1976.
84. Jacobson E. Depression. New York: International Universities Press, 1964.
85. Mohl PC, Lomax J, Tasman A, et al. Psychotherapy training for the psychiatrist of the future. Am J Psychiat 1990; 147:7-13.
86. Olfson M, Klerman GL, Pincus HA. The roles of psychiatrists in organized outpatient mental health settings. Am J Psychiat 1993; 150:625-631.
87. Windle C, Poppen PJ, Thompson JW, Marvelle K. Types of patients served by various providers of outpatient care in CMHCs. Am J Psychiat 1988; 145: 457-463.
88. Scott J. Social and community approaches. In: Paykel ES, ed. Handbook of Affective Disorders. New York: The Guilford Press, 1992.
89. Wolpe J. Psychotherapy by Reciprocal Inhibition. Stanford, California: Stanford University Press, 1958.
90. Beck AT. Cognitive Therapy and the Emotional Disorders. New York: International Universities Press, 1976.
91. Klerman GL, Weissman MM, Rounsaville BJ, Chevron RS. Interpersonal Psychotherapy of Depression. New York: Basic Books, 1984.
92. Agency for Health Care Policy and Research, U.S. Public Health Service. Clinical Practice Guideline Number 5. Depression in Primary Care. Treatment of Major Depression. Vol. 2. Rockville, Maryland, 1993; American Psychiatric Association: practice guideline for major depressive disorder in adults. Am J Psychiat 1993; 150(suppl).
93. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57:414-419.
94. Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull 1990; 108(1):30-49.
95. Gloaguen V, Cottraux J, Cucherat M, et al. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 1998; 49:59-72.
96. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiat 1989; 46:971-982.
97. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine. A double-blind, placebo-controlled trial. Arch Gen Psychiat 1999; 56:431-437.
98. Beach SR, O'Leary KD. Treating depression in the context of marital discord: outcome and predictors of response of marital therapy versus cognitive therapy. Behav Ther 1992; 23:428-507.
99. Neimeyer RA, Robinson LA, Berman JS, et al. Clinical outcome of group therapies for depression. Group Anal 1989; 22:73-86.
100. Propst LR, Ostrom R, Watkins P, et al. Comparative efficacy of religious and nonreligious cognitive-behavioral therapy for the treatment of clinical depression in religious individuals. J Consult Clin Psychol 1992; 60:94-103.
101. Ross M, Scott M. An evaluation of the effectiveness of individual and group cognitive therapy in the treatment of depressed patients in an inner city health centre. J Roy College Gen Pract 1985; 35:239-242.
102. Rude SS. Relative benefits of assertion or cognitive self-control treatment for depression as a function of proficiency in each domain. J Consult Clin Psychiat 1986; 54:390-394.
103. Scott MJ, Stradling SG. Group cognitive therapy for depression produces clinically significant reliable change in community-based settings. Behav Psychother 1990; 18:1-19.
104. Selmi PM, Klein MH, Greist JH, et al. Computer-administered cognitive-behavioral therapy for depression. Am J Psychiat 1990; 147:51-56.
105. Thompson LW, Gallagher D, Breckenridge JS. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 1987; 55: 385-390.
106. Stewart JW, Garfinkel R, Nunes EV, et al. Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacol 1998; 18:429-434.
107. Blackburn IM, Bishop S, Glen AIM, et al. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiat 1981; 139:181-189.
108. Scott C, Tacchi MJ, Jones R, et al. Acute and one-year outcome of a randomised controlled trial of brief cognitive therapy for major depressive disorder in primary care. Br J Psychiat 1997; 171:131-134.
109. Teasdale JD, Fennell MJV, Hibbert GA, et al. Cognitive therapy for major depressive disorder in primary care. Br J Psychiat 1984; 144:400-406.
110. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiat 1997; 171:328-334.
111. Hollon SD, DeRubeis RJ, Evans MD, et al. Cognitive-therapy and pharmacotherapy for depression: singly and in combination. Arch Gen Psychiat 1992; 49:774-781.
112. McKnight DL, Nelson-Gray RO, Barnhill J. Dexamethasone suppression test and response to cognitive therapy and antidepressant medication. Behav Ther 1992; 1:99-111.
113. Murphy GE, Simons AD, Wetzel RD, et al. Cognitive therapy and pharmacotherapy. Arch Gen Psychiat 1984; 41:33-41.
114. Rush AJ, Beck AT, Kovacs M, et al. Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cogn Ther Res 1977; 1:17-38.
115. Murphy GE, Carney RM, Knesevich MA, et al. Cognitive behaviour therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep 1995; 45:403-420.
116. Markowitz JC, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in human immunodeficiency virus-positive patients. Arch Gen Psychiat 1988; 55:452-457.
117. Elkin I, Gibbons RD, Shea MT, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1995; 63:841-847.
118. Watkins JT, Leber WR, Imber SD, et al. Temporal course of change of depression. J Consult Clin Psychol 1993; 61:858-864.
119. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiat 1993; 50: 739-750.
120. Kocsis JH, Rush AJ, Markowitz JC, et al. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacol Bull 2003; 37(4):73-87.
121. McCullough JP. Cognitive Behavioral Analysis System of Psychotherapy: Treatment of Chronic Depression. New York, NY: Guilford Press, 1999.
122. Jacobson NS, Dobson K, Fruzzetti AE, et al. Marital therapy as a treatment for depression. J Consult Clin Psychol 1991; 59:547-557.
123. Gallagher DE, Thompson LW. Treatment of major depressive disorder in older adult outpatients with brief psychotherapies. Psychotherapy 1982; 19:482-490.
124. Jacobson NS, Dobson KS, Truax PA, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 1996; 64:295-304.
125. Shapiro DA, Barkham M, Rees A, et al. Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psycho-dynamic-interpersonal psychotherapy. J Consult Clin Psychol 1994; 62: 522-534.
126. Barkham M, Rees A, Shapiro DA, et al. Outcomes of time-limited psychotherapy in applied settings: replicating the second Sheffield Psychotherapy Project. J Consult Clin Psychol 1996; 64:1079-1085.
127. Hogg JA, Deffenbacher JL. A comparison of cognitive and interpersonal-process group therapies in the treatment of depression among college students. J Consult Clin Psychol 1998; 35:304-310.
128. Rush AJ, Watkins JT. Group versus individual cognitive therapy: a pilot study. Cogn Ther Res 1981; 5:95-103.
129. Beutler LE, Scogin F, Kirkish P, et al. Group cognitive therapy and alprazolam in the treatment of depression in older adults. J Consult Clin Psychol 1987; 55:550-556.
130. Covi L, Lipman RS. Cognitive-behavioral group psychotherapy combined with imipramine in major depression. Psychopharmacol Bull 1987; 23: 173-177.
131. Ravindran AV, Anisman H, Merali Z, et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments. Am J Psychiat 1999; 156:1608-1617.
132. Stuart S, Simons AD, Thase ME, et al. Are personality assessments valid in acute major depression? J Affect Disord 1992; 24:281-290.
133. Wright J, Thase M, Beck A, et al. Cognitive therapy with inpatients. Depression 1993; 1:329-330.
134. Shaw BF. Cognitive therapy with an inpatient population. In: Emery G, Hollon SD, Bedrosian RC, eds. New Directions in Cognitive Therapy. New York: Guilford Press, 1981:29-49.
135. Scott J. Cognitive therapy with depressed inpatients. In: Dryden W, Trower P, eds. Developments in Cognitive Psychotherapy. London: Sage Publications, 1988:177-189.
136. DeJong R, Treiber R, Henrich G. Effectiveness of two psychological treatments for inpatients with severe and chronic depressions. Cogn Ther Res 1986; 10:645-663.
137. Thase ME, Dub S, Bowler K, et al. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients. Am J Psychiat 1996; 153:886-891.
138. Thase ME, Howland RH. Refractory depression: relevance of psychosocial factors and therapies. Psych Ann 1994; 24:232-240.
139. Thase ME, Howland R. Biological processes in depression: updated review and integration. In: Beckham EE, Leber WR, eds. Handbook of Depression. New York, NY: Guilford Press, 1995:213-279.
140. Bowers WA. Treatment of depressed inpatients. Cognitive therapy plus medication, relaxation plus medication, and medication alone. Br J Psychiat 1990; 156:73-78.
141. Miller IW, Norman WH, Keitner GI, et al. Cognitive-behavioral treatment of depressed inpatients. Behav Ther 1989; 20:25-47.
142. Weissman MM, Klerman GL, eds. New Applications of Interpersonal Psychotherapy. Washington, D.C.: American Psychiatric Press, 1993.
143. Barber JP, Muenz LR. The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. J Consult Clin Psychol 1996; 64:951-958.
144. Jarrett RB, Eaves GG, Grannenmann BD, et al. Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Psychiat Res 1991; 37:245-260.
145. Simons AD, Gordon JS, Monroe SM. Toward an integration of psychologic, social, and biologic factors in depression: effects on outcome and course of cognitive therapy. J Consult Clin Psychol 1995; 63:369-377.
146. Thase ME, Reynolds CF III, Frank E, et al. Do depressed men and women respond similarly to cognitive behavior therapy? Am J Psychiat 1994; 151:500-505.
147. Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. Am J Psychiat 1990; 147:711-718.
148. Persons JB, Burns DD, Perloff JM. Predictors of dropout and outcome in cognitive therapy for depression in a private practice setting. Cogn Ther Res 1988; 12:557-575.
149. Burns DD, Nolen-Hoeksema S. Therapeutic empathy and recovery from depression in cognitive-behavioral therapy: a structural equation model. J Consult Clin Psychol 1992; 60:441-449.
150. Simons AD, Epstein LH, McGowan CR, et al. Exercise as a treatment for depression: an update. Clin Psychol Rev 1985; 5:553-568.
151. Kavanaugh DJ, Wilson PH. Prediction of outcome with group cognitive therapy for depression. Behav Res Ther 1989; 27:333-343.
152. Seligman MEP, Castellon C, Cacciola J, et al. Explanatory style change during cognitive therapy for unipolar depression. J Abnorm Psychol 1988; 97:13-18.
153. Fennell MJV, Teasdale JD, Jones S, et al. Distraction in neurotic and endogenous depression: an investigation of negative thinking in major depressive disorder. Psychol Med 1987; 17:441-452.
154. Bryant MJ, Simons AD, Thase ME. Therapist skill and patient variables in homework compliance: controlling an uncontrolled variable in cognitive therapy outcome research. Cogn Ther Res 1999; 23:381-399.
155. Beckham EE. Improvement after evaluation in psychotherapy of depression: evidence of a placebo effect? J Clin Psychol 1989; 45:945-950.
156. Burns DD, Sayers SL, Moras K. Intimate relationships and depression: Is there a causal connection? J Consult Clin Psychol 1994; 62(5):1033-1043.
157. DeRubeis RJ, Feeley M. Determinants of change in cognitive therapy for depression. Cogn Ther Res 1990; 14:469-482.
158. DeRubeis RJ, Evans MD, Hollon SD, et al. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol 1990; 58:862-869.
159. Jacobson NS, Hollon SD. Prospects for future comparisons between drugs and psychotherapy: lessons from the CBT-versus pharmacotherapy exchange. J Consult Clin Psychol 1996; 64:104-108.
160. Reynolds CF III, Miller MD, Pasternak RE, et al. Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiat 1999; 156:202-208.
161. Schneider LS, Sloane RB, Staples FR, et al. Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression. J Clin Psychopharmacol 1986; 6:172-176.
162. DiMascio A, Weissman MM, Prusoff BA, et al. Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiat 1979; 36:1450-1456.
163. Sloane RB, Staples FR, Schneider LR. Interpersonal therapy versus nortriptyline for depression in the elderly. In: Burrows G, Norman TR, Dennerstein L, eds. Clinical and Pharmacological Studies in Psychiatric Disorders. London: John Libbey, 1985:344-346.
164. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiat 1991; 148:997-1008.
165. Brown C, Schulberg HC, Madonia MJ, et al. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiat 1996; 153:1293-1300.
166. Feske U, Frank E, Kupfer DJ, et al. Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: an exploratory investigation. Depression Anxiety 1998; 8:135-141.
167. Schulberg HC, Block MR, Madonia M, et al. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiat 1996; 53:913-919.
168. Lave JR, Frank RG, Schulberg HC, et al. Cost-effectiveness of treatments for major depression in primary care patients. Arch Gen Psychiat 1998; 55: 645-651.
169. Prusoff BA, Weissman MM, Klerman GL, et al. Research Diagnostic Criteria subtypes of depression: their role as predictors of differential response to psychotherapy and drug treatment. Arch Gen Psychiat 1980; 37:796-803.
170. Elkin I, Gibbons RD, Shea MT, et al. Science is not a trial (but it can sometimes be a tribulation). J Consult Clin Psychol 1996; 64:92-103.
171. Buysse D, Kupfer DJ, Frank E, et al. Electroencephalographic sleep studies in depressed patients treated with psychotherapy-I. Baseline studies in responders and nonresponders. Psychiat Res 1992; 42:13-26.
172. Kendall PC, Kipnis D, Otto-Salaj L. When clients don't progress: influences on and explanations for lack of therapeutic progress. Cogn Ther Res 1992; 16:269-281.
173. Weissman MM, Klerman GL, Prusoff BA, et al. Depressed outpatients: results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiat 1981; 38:51-55.
174. Imber SD, Pilkonis PA, Sotsky SM, et al. Mode-specific effects among three treatments for depression. J Consult Clin Psychol 1990; 58:352-359.
175. Klerman GL, DiMascio A, Weissman M, et al. Treatment of depression by drugs and psychotherapy. Am J Psychiat 1974; 131:186-191.
176. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiat 1990; 47:1093-1099.
177. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents [see comment]. Arch Gen Psychiat 2004; 61(6):577-584.
178. Bleiberg KL, Markowitz JC. A pilot study of interpersonal psychotherapy for posttraumatic stress disorder. Am J Psychiat 2005; 162(1):181-183.
179. O'Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiat 2000; 57(11): 1039-1045.
180. Zlotnick C, Johnson SL, Miller IW, Pearlstein T, Howard M. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiat 2001; 158(4):638-640.
181. Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiat 2003; 160(3):555-562.
182. Wilfley DE, Welch RR, Stein RI, et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder [see comment]. Arch Gen Psychiat 2002; 59(8):713-721.
183. Hoberman H, Lewinsohn PM. Behavioral approaches to the treatment of unipolar depression. In: Klerman GL, ed. Treatment of Psychiatric Disorders. Vol. 3. Washington, D.C.: American Psychiatric Association, 1989:1846-1862.
184. Crits-Christoph. The efficacy of brief dynamic psychotherapy: a meta-analysis. Am J Psychiat 1992; 149:151-158.
185. Meterissian GB, Bradwejn J. Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided? J Clin Psychopharmacol 1989; 9:334-339.
186. Hersen M, Bellack AS, Himmelhoch JM, et al. Effects of social skill training, amitriptyline, and psychotherapy in unipolar depressed women. Behav Ther 1984; 15:21-40.
187. McLean PD, Hakstian AR. Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol 1979; 47:818-836.
188. Bellack AS, Hersen M, Himmelhoch JM. A comparison of social-skills training, pharmacotherapy, and psychotherapy for depression. Behav Res Ther 1983; 2:101-107.
189. Brown RA, Lewinsohn PM. A psychoeducational approach to the treatment of depression: comparison of group, individual, and minimal contact procedures. J Consult Clin Psychol 1984; 52:774-783.
190. Lerner MS, Clum GA. Treatment of suicide ideators: a problem-solving approach. Behav Ther 1990; 21:403-411.
191. Nezu AM. Efficacy of a social problem-solving therapy approach for unipolar depression. J Consult Clin Psychol 1986; 54:196-202.
192. Arean PA, Perri MG, Nezu Am, et al. Comparative effectiveness of social problem-solving therapy and reminiscence therapy as treatments for depression in older adults. J Consult Clin Psychol 1993; 61:1003-1010.
193. Fuchs CZ, Rehm LP. A self-control BT program for depression. J Consult Clin Psychol 1977; 45:206-215.
194. Kornblith SJ, Rehm LP, O'Hara MW, et al. The contribution of self-reinforcement training and behavioral assignments to the efficacy of self-control therapy for depression. Cogn Ther Res 1983; 7:499-528.
195. Rehm LP, Fuchs CZ, Roth DM, et al. A comparison of self-control and assertion skills treatment of depression. Behav Ther 1979; 10:429-442.
196. Rehm LP, Kornblith SJ, O'Hara MW, et al. An evaluation of major components in a self-control therapy program for depression. Behav Mod 1981; 5:459-489.
197. Rehm LP, Kaslow NJ, Rabin AS. Cognitive and behavioral targets in a self-control therapy program for depression. J Consult Clin Psychol 1987; 55: 60-67.
198. Lewinsohn PM, Antonuccio DA, Steinmetz J, et al. The Coping with Depression Course: A Psychoeducational Intervention for Unipolar Depression. Eugene, Oregon: Castalia Press, 1984.
199. Mynors-Wallis LM, Gath DH, Lloyd-Thoms AR, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. Gen Pract 1995; 310: 441-445.
200. Gabbard GO. Psychodynamic Psychiatry in Clinical Practice. In: Psycho-dynamic Psychiatry in Clinical Practice. 3rd. Washington, D.C.: American Psychiatric Press, 2004.
201. Gabbard GO. Long-Term Psychodynamic Psychotherapy: A Basic Text. Washington, D.C.: American Psychiatric Publishing, 2004.
202. Groves JE, ed. Essential Papers on Short-Term Dynamic Therapy. New York: New York University Press, 1996.
203. Coynes JC, ed. Essential Papers on Depression. New York, NY: University Press, 1986.
204. Busch FN, Rudden M, Shapiro T. Psychodynamic Treatment of Depression. D.C.: American Psychiatric Publishing, Inc., 2004.
205. Levy R, Ablon JS. Psychoanalytic research: progress and process. Psychoanal Psychol 2000; 23:23-25.
206. Fonagy P, ed. Open Door Review of Outcome Studies in Psychoanalysis. 2d ed. London: International Psychoanalytical Association, 2002.
207. Wallerstein RS. Outcome research. In: Person ES, Cooper AM, Gabbard, GO, eds. American Psychiatric Publishing Textbook of Psychoanalysis, 2005: 301-315.
208. Bucci W. Process research. In: Person ES, Cooper AM, Gabbard GO, eds. American Psychiatric Publishing Textbook of Psychoanalysis, 2005:317-333.
209. Westen D, Novotny C, Thompson-Brenner H. The empirical status of empirically-supported psychotherapies: assumptions, findings, and reporting in clinical trials. Psychol Bull 2004; 130(4):631-663.
210. Westen D, Novotny C, Thompson-Brenner H. The new generation of psychotherapy research: reply to Ablon and Marci (2004), Goldfried and Eubanks-Carter (2004), and Haaga (2004). Psychol Bull 2004; 130(4):677-683.
211. Westen D, Novotny C, Thompson-Brenner H. EBP ≠ EST: reply to Crits-Cristoph et al. (2005) and Weiz et al. (2005). Psychol Bull 2005; 131(3): 427-433.
212. Blatt SJ, Levy KN. A psychodynamic approach to the diagnosis of psychopathology. In: Barron JW, ed. Making Diagnosis Meaningful 73-109. Washington, D.C.: American Psychological Association Press, 1998.
213. Barkham M, Rees A, Stiles Shapiro DA, Hardy GE, Reynolds S. Dose-effect relations in time-limited psychotherapy for depression. J Clin Consult Psychol 1996; 64(5):927-935.
214. Knedt P, Lindfors O, eds. A Randomized Trial of the Effects of Four Forms of Psychotherapy on Depression and Anxiety Disorders: Design Methods and Results on the Effectiveness of Short-Term Psychodynamic Psychotherapy and Solution-Focused Therapy During a 1-Year Follow-Up. Vol. 77. Helsinki: Social Insurance Institution, 2004.
215. Maina G, Forner F, Bogetto F. Randomized controlled trial comparing brief dynamic and supportive therapy with waiting list control in minor depressive disorders. Psychother Psychosomat 2005; 74(1):43-50.
216. Copper L, Cooper P, Wilson A, Romaniuk H. Controlled trial of the shortand long-term effect of psychological treatment of post-partum depression: impact on the mother-child relationship and child outcome. Br J Psychiat 2003; 182(5):420-427.
217. Burnand Y. Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiat Serv 2002; 53(5):585-590.
218. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baity MR, Mooney MA. Shortterm psychodynamic psychotherapy for depression: an examination of statistical, clinically significant, and technique-specific change. J Nerv Mental Dis 2003; 191(6):349-357.
219. Bond M, Perry CJ. Long-term changes in defense styles with psychodynamic psychotherapy for depressive, anxiety, and personality disorders. Am J Psychiat 2004; 161:1665-1671.
220. Barber J, Abrams MJ, Connolly-Gibbons MB, et al. J Clin Psychol 2005; 16(3):257-268.
221. Wampold B. The Great Psychotherapy Debate. Mahwah, NJ: Lawrence Erlbaum, 2001.
222. Leichsenring F. Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach. Clin Psychol Rev 2001; 21(3):401-419.
223. Fisher S, Greenberg R. Freud Scientifically Reappraised: Testing the Theories and the Therapies. New York: Wiley and Sons, 1996.
224. Ablon JS, Jones EE. Validity of controlled clinical trials of psychotherapy: findings from the NIMH collaborative study of depression. Am J Psychiat 2002; 159:775-783.
225. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiat 2005; 66: 455-468.
226. Murphy GE, Simons AD, Wetzel RD, et al. Cognitive therapy and pharmacotherapy, singly and together, in the treatment of depression. Arch Gen Psychiat 1984; 41:33-41.
227. Conte HR, Plutchik R, Wild KV, et al. Combined psychotherapy and pharmacotherapy for depression. Arch Gen Psychiat 1986; 43:471-479.
228. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy-pharmacotherapy combinations. Arch Gen Psychiat 1997; 54:1009-1015.
229. Friedman MA, Detweiler-Bedell JB, Leventhal HE, et al. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract 2004; 11:47-68.
230. Pampallona S, Bollini P, Tiabaldi G, et al. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiat 2004; 61:714-719.
231. Keller MB, McCullough JP, Klein DN, et al. A comparison ofnefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342:1462-1470.
232. Klerman GL, Weissman MM. Interpersonal psychotherapy: theory and research. In: Rush AJ, ed. Short-Term Psychotherapies for Depression. New York: Guilford Press, 1982:88-106.
233. Safran JD, Segal ZV, Vallis TM, et al. Assessing patient suitability for shortterm cognitive therapy with an interpersonal focus. Cogn Ther Res 1993; 17:23-28.
234. Thase ME, Buysse DJ, Frank E, et al. Which depressed patients will respond to interpersonal psychotherapy? The role of abnormal electroencephalographic sleep profiles. Am J Psychiat 1997; 154:502-509.